The Nervous System Study

Currently Recruiting

18 Nov 2025 to 18 Dec 2025

Up to $4,758

The objective of this study is to evaluate the safety and tolerability of a new investigational treatment for Friedreich’s ataxia in healthy volunteers. Your participation will help us gather crucial data to advance our research and move closer to a potential treatment for FA.

Apply now Speak with us

Join our clinical trial

We invite you to join our Phase 1 clinical study aimed at finding a treatment for Friedreich’s ataxia (FA).

Friedreich’s ataxia (FA) is a rare genetic disease that typically begins in childhood, between the ages of 5 and 15. It affects movement, speech, and daily activities. Over time, FA can lead to a loss of mobility and other serious health issues such as heart problems and diabetes, often shortening life expectancy to the 30s or 40s.

By participating, you can offer hope to affected families and contribute to a future where FA no longer limits lives.

Nucleus Network - Image

Why participate?

  • Contribute to Groundbreaking Research: Your participation can help advance our understanding and treatment of FA.
  • Support Families: Offer hope and support to families affected by FA.
  • Be Part of a Community: Join a community dedicated to making a difference.

Trial details

Study medication

Administered in one of three ways: subcutaneous infusion,
subcutaneous injection or intravenous (IV) infusion.

Ethics

  • This is the first time the study drug is being administered to humans, so there may be unknown risks involved. However, this clinical trial has been carefully designed to minimize risks for participants. Before you decide to participate, you will receive detailed information about the trial, including its risks and our mitigation strategies. You will also have an appointment with one of our doctors, who will be happy to answer any questions you may have.
  • An independent ethics committee has approved this clinical trial.
  • Participants will be reimbursed for their time.

Study duration

4-night in-clinic stay, 4 follow-up visits and 1 phone call

Are you a match?

Age

18 - 45 years old

Remuneration

Up to $4,758 *with screening reimbursement. Please see T&Cs.

Gender

Male or Female

BMI

BMI 16 - 32 kg/m2

Commitment

4 nights, 1 clinic visit

Register Your Interest

This form takes around 3–5 minutes to complete. Your information will remain confidential and is used only to assess your eligibility for current or future research studies.
Step 1 of 3
Contact Information




The phone number you have entered does not appear to be a valid active Australian phone number. Please check your details and enter a valid Australian phone number starting with +61

Nucleus Network does not currently conduct clinical trials in your state. If you would like to receive study information should this situation change, please complete and submit this form.
Personal Information

This includes registering your interest with the Centre for Clinical Studies, Q-Pharm or Nucleus Network

Please call us on 1800 243 733 or schedule a call.


What is your date of birth?
Day Month Year

You need to be at least 18 years old to participate in clinical trials.


cm

kg





















Step 2 of 3
Medical History

We regularly have studies that allow participants who are (social) smokers.

We define an allergy as severe if symptoms include mouth/throat/face swelling, shortness of breath or a whole-body rash, or if it required hospitalisation

We regularly have studies that allow for/require participants with asthma.



We regularly have studies that allow for/require participants with medical conditions.

Medications & Contraception Requirements

We regularly have studies that allow participants with depression that is well-managed on a stable dose of medication.

If the only prescription medication you currently use is hormonal contraception and/or Ventolin, please select No above. We regularly have studies that allow for participants who take a stable dose of prescription medication.


  • Abstinence from sex with anyone of the opposite sex for at least 2 months
  • Using a condom + your female sexual partner(s) using a separate form of birth control
  • You or your sexual partner(s) had a vasectomy/hysterectomy
  • Your sexual partner(s) are post-menopausal


Only you taking birth control or your partner(s) using a condom is not an acceptable option, but using both together is. The morning after pill is not an acceptable form of birth control.

  • Abstinence, by choice, from sex with anyone of the opposite sex for the last 2 months + remaining abstinent for at least 2 months after study participation
  • You using birth control + your male sexual partner(s) using a condom
  • You or your sexual partner(s) had a hysterectomy/vasectomy
  • You are post-menopausal



Step 3 of 3
Study Preferences

While longer studies generally have a higher reimbursement, there are also studies with multiple short stays that have high reimbursements.
Referral Information



Consent to Information Use and Future Contact